These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 809627)

  • 1. Alloimmunization to HL-A antigens and hemolytic disease of newborns on the background of incompatibility in the Rh system.
    Turowski G; Morawska A; Turowska B
    Mater Med Pol; 1975; 7(3):210-5. PubMed ID: 809627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-HL-A immunization and lethal forms of Rh hemolytic disease].
    Moulinier J
    Pathologica; 1972; 64(927):39-41. PubMed ID: 4629915
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of free and bound Rh antibodies in Rh (c) hemolytic disease of the newborn].
    Spasova K; Vulcheva B; Purvanova Z
    Akush Ginekol (Sofiia); 1979; 18(1):17-9. PubMed ID: 107823
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemolytic disease of the newborn due to alloimmunization as a consequence of multiple transfusions and a delayed hemolytic transfusion reaction in the mother.
    Kanra T; Erdoğan S; Yurdakök M; Erdem G
    Turk J Pediatr; 1983; 25(2):129-33. PubMed ID: 6422599
    [No Abstract]   [Full Text] [Related]  

  • 5. HL-A antibodies and some immunological problems of pregnancy.
    Imre G; Keserü TL; Maráz A; Hetyei P
    Folia Biol (Praha); 1971; 17(6):414-7. PubMed ID: 5002841
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between maternal HL-A immunization and familial prognosis of haemolytic disease of the newborn due to Rh incompatibility].
    Malinvaud G; Gualde N
    Rev Fr Transfus Immunohematol; 1975 Sep; 18(3):269-80. PubMed ID: 821129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some factors influencing Rh immunization during pregnancy.
    Cooke BR; Bradley MA; Walsh RJ
    Med J Aust; 1965 Sep; 2(11):437-41. PubMed ID: 4953260
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte subpopulations in healthy newborns and in immunohemolytic anemia due to Rh incompatibility.
    Maślanka K; Zupańska B; Lozińska D; Brojer E
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):21-8. PubMed ID: 6793019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complement factors C'1-C'4) in maternal and infant serum in Rh-dependent hemolytic disease of newborn].
    Tacke A; Schneeweiss B; Ullrich E; Ijaiya K
    Padiatr Grenzgeb; 1972; 11(5):381-5. PubMed ID: 4200376
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neonatal thrombopenia and hemolytic disease of the newborn due to Rh incompatibility].
    Malinvaud G; Borie R
    Rev Fr Transfus; 1969; 12(1):Suppl:277-90. PubMed ID: 4987779
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fetomaternal immunization of women during pregnancy with HL-A alloantigens and ABO and Rh antigens].
    Zdebski Z
    Folia Med Cracov; 1974; 16(2):235-46. PubMed ID: 4208466
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prenatal immunological research on hemolytic disease of the newborn].
    Gota F; Dallavalle FM
    Arch Sci Med (Torino); 1980; 137(4):563-5. PubMed ID: 6788016
    [No Abstract]   [Full Text] [Related]  

  • 13. [Frequency and significance of leucocyte iso-antibodies in women with Rh-incompatibility (author's transl)A1].
    Hübel E; Bertrams J; Kuwert E; Luboldt W; Fischer K
    Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):411-8. PubMed ID: 4282923
    [No Abstract]   [Full Text] [Related]  

  • 14. [Unusual aspects of neonatal hemolytic disease].
    Lange MM; Lumare A; Baratono S
    Minerva Pediatr; 1967 Aug; 19(31):1466-7. PubMed ID: 4975678
    [No Abstract]   [Full Text] [Related]  

  • 15. [Feto-maternal incompatibility in the Rh system. Hemolytic disease of the fetus].
    Merger R
    J Gynecol Obstet Biol Reprod (Paris); 1972 Mar; 1(2):105-6. PubMed ID: 4626033
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fetomaternal immunization of pregnant women to HL-A alloantigens and ABO and Rh antigens. II. Clinical observations on the course of pregnancy].
    Zdebski Z
    Folia Med Cracov; 1974; 16(3):341-53. PubMed ID: 4212657
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correlation between the presence of cytotoxic anti-HL-A antibodies in the clinical course of hemolytic disease of the newborn infant due to anti-Rh (D) or immune anti-A/B erythrocyte antibodies].
    Gligorović VN; Gligorović S; Susaković N; Lopicić L; Stolić I; Marković V; Matejić T
    Bilt Hematol Transfuz; 1976; 4(3):23-31. PubMed ID: 827283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HL-A antibodies: influence on the human foetus.
    Ahrons S
    Tissue Antigens; 1971; 1(3):129-36. PubMed ID: 5005219
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunohematology of hemolytic disease of the newborn].
    Hrubisko M
    Cesk Gynekol; 1969 Oct; 34(8):465-9. PubMed ID: 4187682
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research on the passage of isohemagglutinins into milk in hemolytic disease of the newborn].
    Lange MM; Fiandino G
    Minerva Pediatr; 1967 Sep; 19(38):1728-34. PubMed ID: 4976636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.